Seagen
SGEN
#541
Rank
$43.15 B
Marketcap
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)

Seagen (SGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2023 : $1.08 Billion USD

According to Seagen 's latest financial reports the company's total liabilities are $1.08 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Seagen - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31$0.87 B33.04%
2021-12-31$0.65 B27.62%
2020-12-31$0.51 B55.59%
2019-12-31$0.32 B43.68%
2018-12-31$0.22 B14.48%
2017-12-31$0.20 B-1.92%
2016-12-31$0.20 B-2.33%
2015-12-31$0.20 B-15.7%
2014-12-31$0.24 B-2.2%
2013-12-31$0.25 B3.44%
2012-12-31$0.24 B18.85%
2011-12-31$0.20 B22.53%
2010-12-31$0.16 B-7.53%
2009-12-31$0.18 B67.56%
2008-12-31$0.10 B14.97%
2007-12-31$94.54 M899.3%
2006-12-31$9.46 M-35.03%
2005-12-31$14.56 M-4.68%
2004-12-31$15.27 M114.52%
2003-12-31$7.12 M22.06%
2002-12-31$5.83 M147.51%
2001-12-31$2.35 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$121.38 B 11,099.53%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$137.18 B 12,557.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$11.18 B 931.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$71.53 B 6,499.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$60.82 B 5,511.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
$80.87 M-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
$0.26 B-75.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$55.81 M-94.85%๐Ÿ‡บ๐Ÿ‡ธ USA